Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis

  24 December 2024

This systematic review and meta-analysis aimed to assess the global prevalence of antibiotic resistance in pediatric Helicobacter pylori infection. The study found that primary resistance rates were metronidazole 35.3%, clarithromycin 32.6%, tetracycline 2.1%, levofloxacin 13.2%, and amoxicillin 4.8%. Raising antibiotic resistance was detected in most WHO regions. The escalating trend of H. pylori antibiotic resistance in children warrants urgent global attention and the need for national and regional surveillance networks for antibiotic stewardship.

Further reading: BMC Medicine
Author(s): Aryan Salahi-Niri et al
Effective Surveillance   Kids and Carers  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed